Atlas Trials

Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer

Clinical trial NCT06103617 · UNKNOWN

Trial details

NCT number
NCT06103617
Sponsor
Nanfang Hospital, Southern Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck CancerRecurrent Cancer
Start date
2023-11-15
Primary completion
2024-10-30
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.